Novartis/Boehringer-Ingelheim Serentil
Executive Summary
Boxed warning about potential QTc prolongation associated with antipsychotic mesoridazine is added to labeling, and product is restricted to second-line status. The change is similar to a July relabeling for Novartis' chemically-related product Mellaril (1"The Pink Sheet" July 17, p. 12). Mesoridazine is a Mellaril (thioridazine) metabolite